Singapore markets close in 6 hours 12 minutes

Spago Nanomedical AB (publ) (7UX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0190+0.0010 (+5.56%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,465
1,203
1,054
660
342
-
Cost of revenue
16,917
24,486
16,658
17,436
758
-
Gross profit
-15,452
-23,283
-15,604
-16,776
-416
-
Operating expenses
Selling general and administrative
-
-
8,071
7,542
5,212
6,242
Total operating expenses
19,302
19,222
23,481
22,291
18,537
-
Operating income or loss
-34,754
-42,505
-39,085
-39,067
-18,953
-
Income before tax
-34,413
-42,223
-39,197
-39,071
-18,928
-
Income from continuing operations
-34,413
-42,223
-39,197
-39,071
-18,928
-
Net income
-34,413
-42,223
-39,197
-39,071
-18,928
-
Net income available to common shareholders
-34,413
-42,223
-39,197
-39,071
-18,928
-
Basic EPS
-0.40
-0.43
-0.58
-0.95
-0.66
-
Diluted EPS
-0.40
-0.43
-0.58
-0.95
-0.66
-
Basic average shares
95,294
97,978
66,808
41,262
28,845
-
Diluted average shares
95,305
104,955
67,189
41,851
29,442
-